4//SEC Filing
Shabtai Gilad 4
Accession 0001209191-18-024125
CIK 0001035354other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 6:08 PM ET
Size
7.1 KB
Accession
0001209191-18-024125
Insider Transaction Report
Form 4
Shabtai Gilad
10% Owner
Transactions
- Purchase
Common Stock
2018-04-04$9.58/sh+2,600$24,908→ 3,276,770 total - Purchase
Common Stock
2018-04-03$9.41/sh+5,700$53,637→ 3,274,170 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.39 to $9.413, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.50 to $9.69666, inclusive.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001726027
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 6:08 PM ET
- Size
- 7.1 KB